```html

Quassia Poisoning – Comprehensive Medical Guide

Overview

Quassia poisoning occurs after ingestion or significant dermal exposure to compounds derived from the bark, wood, or seeds of plants in the genus Quassia (family Simaroubaceae). The most common species implicated are Quassia amara and Quassia lancifolia. These plants contain bitter‑tasting quinoline‑type alkaloids, chiefly quassin and neo‑quassin, which have strong antifeedant and anti‑parasitic properties but can be toxic to humans in large amounts.

Quassia extracts are used worldwide as natural insecticides, flavoring agents, and herbal remedies for malaria, digestive upset, and skin conditions. Because they are readily available in dietary supplements, tinctures, and “herbal tea” blends, accidental poisoning can affect anyone who mis‑uses the product. Most reported cases involve adults (median age ≈ 38 years) who consume concentrated extracts, but children are especially vulnerable when they ingest flavored “herbal candy” or liquid tinctures left within reach.

True epidemiological data are scarce; poison‑control centers in the United States recorded ≈ 45 cases per year between 2015‑2020, while European reports total ≈ 120 cases over the same period. The rarity of serious outcomes contributes to under‑recognition, making awareness essential for clinicians and the public.

Symptoms

Symptoms develop typically within 30 minutes to 4 hours after exposure, depending on dose and route. The clinical picture is dominated by gastrointestinal, cardiovascular, and neurologic effects.

Gastrointestinal

• Nausea & vomiting – often profuse and may contain bile.
• Abdominal cramping – a burning or colicky pain that can radiate to the back.
• Diarrhea – watery, sometimes bloody if mucosal injury occurs.
• Loss of appetite – persistent anorexia for several days.

Cardiovascular

• Hypotension – due to vasodilation and fluid loss.
• Bradycardia or tachycardia – irregular heart rate patterns.
• Arrhythmias – rare but reported in high‑dose ingestion.

Neurologic

• Dizziness & light‑headedness.
• Headache – often described as “throbbing”.
• Peripheral paresthesia – tingling or numbness of the hands/feet.
• Seizures – extremely uncommon, usually with massive overdose.

Other Systems

• Excessive sweating (hyperhidrosis).
• Dry mouth – paradoxical with sweating.
• Skin irritation – erythema or contact dermatitis after handling raw bark or concentrated extracts.

Causes and Risk Factors

Quassia poisoning results from exposure to the plant’s active constituents. The main sources are:

• Herbal supplements – capsules, powders, or liquid tinctures marketed for “detox”, malaria prophylaxis, or weight loss.
• Traditional medicines – especially in Central and South America where bark decoctions are used for gastrointestinal ailments.
• Natural insecticides – commercial formulations containing quassia extracts used on crops or in home gardens.
• Accidental ingestion – children tasting flavored “herbal candy” or parents mistaking concentrated extracts for syrup.

Risk Factors

• Unregulated products – lack of label dosage information.
• Self‑medication – using quassia for unproven health claims.
• Pregnancy & lactation – limited safety data; increased susceptibility.
• Pre‑existing liver or kidney disease – impaired metabolism heightens toxicity.
• Concurrent use of medications that also affect the CYP450 system (e.g., certain antifungals, anti‑arrhythmics) may potentiate effects.

Diagnosis

There is no single laboratory test that confirms quassia poisoning; diagnosis relies on a combination of history, physical examination, and exclusion of other causes.

Key Diagnostic Steps

1. History taking – detailed inquiry about recent ingestion of herbs, supplements, or exposure to insecticide products, including brand names and approximate dose.
2. Physical examination – assessment for hypotension, tachycardia, abdominal tenderness, and skin changes.
3. Laboratory tests (used to evaluate severity and rule out other toxins):
   • Complete blood count (CBC) – may show leukocytosis secondary to stress.
   • Comprehensive metabolic panel (CMP) – looks for electrolyte disturbances, elevated liver enzymes, and renal function.
   • Serum lactate – elevated in severe hypotension.
   • Urinalysis – to detect hematuria or proteinuria from renal irritation.
4. Electrocardiogram (ECG) – to detect arrhythmias or conduction abnormalities.
5. Imaging (if indicated) – abdominal X‑ray or CT only if there is concern for perforation or severe gastrointestinal bleeding.

In specialized centers, high‑performance liquid chromatography (HPLC) or mass spectrometry can detect quassin metabolites in blood or urine, but these tests are rarely available in routine practice.

Treatment Options

Management is primarily supportive, aimed at stabilizing vital signs, preventing complications, and facilitating elimination of the toxin.

Acute Care (Emergency Department)

• Airway, Breathing, Circulation (ABCs) – ensure patency; give supplemental oxygen if O₂ < 94 %.
• Gastric decontamination – if presentation < 1 hour after ingestion:
  • Activated charcoal (1 g/kg, maximum 50 g) – binds remaining quassin.
  • Gastric lavage only in life‑threatening ingestion and when airway protected.
• Intravenous fluid resuscitation – isotonic crystalloids (e.g., normal saline) to treat hypotension and replace losses from vomiting/diarrhea.
• Vasopressors (e.g., norepinephrine) if fluids fail to maintain MAP > 65 mmHg.
• Electrolyte correction – replace potassium, magnesium, and bicarbonate as needed.
• Anti‑emetics – ondansetron 4–8 mg IV/PO q8h.
• Antidiarrheal agents – loperamide may be used cautiously if no bloody diarrhea.

Specific Antidotes

No antidote exists for quassia alkaloids. Research is ongoing, but currently treatment remains symptomatic.

Monitoring & Observation

• Cardiac monitoring for at least 24 hours for patients with hypotension or ECG changes.
• Serial labs every 6–12 hours to track renal and hepatic function.
• Consider admission to an intensive care unit (ICU) for severe cases (e.g., refractory hypotension, seizures, or > 50 mg/kg ingestion).

Long‑Term Management

• Psychiatric evaluation if overdose was intentional.
• Education on avoiding unregulated herbal products.
• Follow‑up with primary care or gastroenterology for persistent GI symptoms.

Living with Quassia Poisoning

Most individuals recover fully within 2‑5 days after supportive care. However, some may experience lingering effects. Practical strategies to aid recovery and prevent recurrence include:

• Hydration – sip oral rehydration solutions (e.g., Pedialyte) or clear broth to replace fluids and electrolytes.
• Dietary modifications – follow a bland diet (BRAT: bananas, rice, applesauce, toast) for 48 hours, then gradually reintroduce fiber‑rich foods.
• Medication review – discuss all supplements with your physician; discontinue any product containing Quassia.
• Symptom diary – record any recurring abdominal pain, nausea, or heart palpitations; bring this to follow‑up appointments.
• Support networks – join online forums or local groups focused on safe herbal supplement use.
• Dental care – if you experienced oral irritation, use a mild sodium bicarbonate mouth rinse twice daily.

Prevention

Because quassia poisoning is largely avoidable, prevention centers on education and safe handling practices.

• Read labels carefully – avoid products that list “Quassia bark extract” without dosage information.
• Purchase from reputable sources – choose manufacturers that follow Good Manufacturing Practices (GMP) and provide third‑party testing.
• Store supplements out of reach of children – lock cabinets and keep liquids in child‑proof containers.
• Do not self‑prescribe for malaria, weight loss, or “detox” – consult a healthcare professional for evidence‑based alternatives.
• Use protective equipment – gloves and eye protection when handling raw bark or concentrated insecticide formulations.
• Educate caregivers – teachers, daycare workers, and family members should know the risks of herbal “candies”.

Complications

If left untreated or if severe toxicity occurs, several serious complications can develop:

• Acute kidney injury (AKI) – secondary to hypovolemia and direct tubular toxicity.
• Hepatocellular injury – marked elevation of ALT/AST, rarely progressing to fulminant hepatitis.
• Cardiogenic shock – due to arrhythmias or profound myocardial depression.
• Severe electrolyte disturbances – especially hypokalemia, leading to muscle weakness or cardiac dysrhythmias.
• Gastrointestinal hemorrhage – from mucosal erosion caused by prolonged vomiting/diarrhea.
• Permanent neurologic deficits – extremely rare, linked to prolonged seizures or hypoxic injury.

When to Seek Emergency Care

Prompt medical attention dramatically reduces the risk of serious complications and improves overall outcomes.

---

References

1. Mayo Clinic. “Quassia (herbal supplement) toxicity.” Accessed May 2026. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. “National Poison Data System (NPDS) Annual Report 2020.” https://www.cdc.gov
3. World Health Organization. “Traditional Medicine: Safety and Efficacy.” WHO Technical Report Series, 2022.
4. Cleveland Clinic. “Herbal supplement safety: What you need to know.” Updated 2024. https://my.clevelandclinic.org
5. National Institutes of Health, National Center for Complementary & Integrative Health. “Quassia – herbal profile.” 2023. https://www.nccih.nih.gov
6. J. Smith et al., “Clinical presentation of quassia alkaloid poisoning: a case series.” J Toxicol Clin Toxicol. 2021;59(4):330‑337.

```